A look at the weighted underlying holdings of the First Trust NYSE Arca Biotechnology Index Fund (Symbol: FBT) shows an impressive 13.0% of holdings on a weighted basis have experienced insider buying within the past six months.
Juno Therapeutics Inc (Symbol: JUNO), which makes up 3.61% of the First Trust NYSE Arca Biotechnology Index Fund (Symbol: FBT), has seen 2 directors and officers purchase shares in the past six months, according to the recent Form 4 data. The ETF holds a total of $37,791,379 worth of JUNO, making it the #4 largest holding. The table below details the recent insider buying activity observed at JUNO:
JUNO - last trade: $31.36 - Recent Insider Buys:
|03/10/2017||Anthony B. Evnin||Director||8,000||$22.11||$176,885|
|05/26/2017||Jay T. Flatley||Director||20,000||$24.76||$495,217|
|06/20/2017||Anthony B. Evnin||Director||9,000||$24.40||$219,600|
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Latest Markets Videos
- Stimulus Update: MIllions Will Get a Stimulus Check in June. Are You One of Them?
- Is the Stock Market Open on Independence Day 2022?
- Social Security Checks Could Soar in 2023: Here's How Much Extra Seniors Might Receive
- Used Car Prices Are Starting to Drop From All-Time Highs. Is the Worst Behind Us?